Pharmabiz2h
US FDA grants priority review status to Johnson & Johnson’s nipocalimab BLA to treat generalized myasthenia gravis
US FDA grants priority review status to Johnson & Johnson’s nipocalimab BLA to treat generalized myasthenia gravis: Spring House, Pennsylvania Saturday, January 11, 2025, 12:00 ...
Pharmabiz6h
EU looks at India as best option over China, reflecting potential shifts in trade dynamics
EU looks at India as best option over China, reflecting potential shifts in trade dynamics: Nandita Vijayasimha, Bengaluru Saturday, January 11, 2025, 08:00 Hrs [IST] The European ...
EU regulators take a hard look at Elon Musk and X
The Digital Services Act allows the EU to impose hefty fines and even block the platform.Under the Digital Services Act, Elon ...
Healio12h
Brimochol PF achieves endpoints in second phase 3 presbyopia trial
Patients with presbyopia experienced improvements in near vision after treatment with Brimochol PF in a second phase 3 ...
Data-driven study reveals falling use of antiseizure drug in pregnancy
University of Liverpool researchers have contributed to the largest study to date on sodium valproate use. This significant ...
4DMT Focuses Pipeline to Prioritize 4D-150 in Wet AMD & DME and 4D-710 in CF and Extends Cash Runway
Strategically focused pipeline optimizes resource allocation to progress two product candidates with strongest clinical proof of concept: 4D-150 ...
Inozyme Pharma Announces Positive Interim Data for INZ-701 in Infants and Young Children with ENPP1 Deficiency and Key Program Updates
Positive interim results in infants and young children with ENPP1 Deficiency showed improvements from baseline in multiple measures of disease, ...